Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/142055
Title: Scaffold-mediated sustained, non-viral delivery of miR-219/miR-338 promotes CNS remyelination
Authors: Milbreta, Ulla
Lin, Junquan
Pinese, Coline
Ong, William
Chin, Jiah Shin
Shirahama, Hitomi
Mi, Ruifa
Williams, Anna
Bechler, Marie E.
Wang, Jun
ffrench-Constant, Charles
Hoke, Ahmet
Chew, Sing Yian
Keywords: Engineering::Bioengineering
Issue Date: 2018
Source: Milbreta, U., Lin, J., Pinese, C., Ong, W., Chin, J. S., Shirahama, H., . . . Chew, S. Y. (2019). Scaffold-mediated sustained, non-viral delivery of miR-219/miR-338 promotes CNS remyelination. Molecular Therapy, 27(2), 411-423. doi:10.1016/j.ymthe.2018.11.016
Journal: Molecular Therapy
Abstract: The loss of oligodendrocytes (OLs) and subsequently myelin sheaths following injuries or pathologies in the CNS leads to debilitating functional deficits. Unfortunately, effective methods of remyelination remain limited. Here, we present a scaffolding system that enables sustained non-viral delivery of microRNAs (miRs) to direct OL differentiation, maturation, and myelination. We show that miR-219/miR-338 promoted primary rat OL differentiation and myelination in vitro. Using spinal cord injury as a proof-of-concept, we further demonstrate that miR-219/miR-338 could also be delivered non-virally in vivo using an aligned fiber-hydrogel scaffold to enhance remyelination after a hemi-incision injury at C5 level of Sprague-Dawley rats. Specifically, miR-219/miR-338 mimics were incorporated as complexes with the carrier, TransIT-TKO (TKO), together with neurotrophin-3 (NT-3) within hybrid scaffolds that comprised poly(caprolactone-co-ethyl ethylene phosphate) (PCLEEP)-aligned fibers and collagen hydrogel. After 1, 2, and 4 weeks post-treatment, animals that received NT-3 and miR-219/miR-338 treatment preserved a higher number of Olig2+ oligodendroglial lineage cells as compared with those treated with NT-3 and negative scrambled miRs (Neg miRs; p < 0.001). Additionally, miR-219/miR-338 increased the rate and extent of differentiation of OLs. At the host-implant interface, more compact myelin sheaths were observed when animals received miR-219/miR-338. Similarly within the scaffolds, miR-219/miR-338 samples contained significantly more myelin basic protein (MBP) signals (p < 0.01) and higher myelination index (p < 0.05) than Neg miR samples. These findings highlight the potential of this platform to promote remyelination within the CNS.
URI: https://hdl.handle.net/10356/142055
ISSN: 1525-0016
DOI: 10.1016/j.ymthe.2018.11.016
Rights: © 2018 The American Society of Gene and Cell Therapy. All rights reserved. This paper was published in Molecular Therapy and is made available with permission of The American Society of Gene and Cell Therapy.
Fulltext Permission: open
Fulltext Availability: With Fulltext
Appears in Collections:SCBE Journal Articles

Files in This Item:
File Description SizeFormat 
Scaffold-mediated sustained non-viral delivery of miR-219.pdf2.25 MBAdobe PDFView/Open

SCOPUSTM   
Citations 10

19
Updated on Mar 10, 2021

PublonsTM
Citations 10

18
Updated on Mar 7, 2021

Page view(s)

39
Updated on May 14, 2021

Download(s)

4
Updated on May 14, 2021

Google ScholarTM

Check

Altmetric


Plumx

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.